\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ within\\ normal\\ limits\ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ abdomen\\:\\ soft\\,\\ normoactive\\ bowel\\ sounds\\,\\ no\\ distention\\ or\\ organomegaly\\ appreciated\\.\\ mild\\ tenderness\\ to\\ palpation\\ diffusely\\ but\\ more\\ pronounced\\ in\\ the\\ suprapubic\\ area\\.\\ no\\ rebound\\ or\\ guarding\\ observed\ \(0\)\
\-\ other\\ systems\\ within\\ normal\\ limits\\.\\ \ \(0\)\
\-\ laboratory\\ results\\:\ \(0\)\
\-\ cbc\\,\\ cmp\\,\\ esr\\ and\\ crp\\ within\\ normal\\ limits\ \(0\)\
\-\ negative\\ stool\\ guaiac\\ and\\ normal\\ fecal\\ calprotectin\ \(0\)\
\-\ urinalysis\\ at\\ the\\ time\\ of\\ admission\\:\\ within\\ normal\\ limits\ \(0\)\
\-\ color\\:\\ yellow\ \(1\)\
\-\ appearance\\:\\ hazy\ \(1\)\
\-\ ph\\:\\ 7\\.0\ \(0\)\
\-\ glucose\\:\\ negative\ \(1\)\
\-\ ketones\\:\\ negative\ \(1\)\
\-\ bilirubin\\:\\ negative\ \(1\)\
\-\ nitrites\\:\\ negative\ \(1\)\
\-\ leukocyte\\ esterase\\:\\ moderate\ \(1\)\
\-\ blood\\:\\ negative\ \(1\)\
\-\ urobilinogen\\:\\ 0\\.2\\ \\(reference\\ range\\:\\ 0\\.2\\-1\\.0\\)\ \(0\)\
\-\ protein\\:\\ negative\ \(1\)\
\-\ specific\\ gravity\\:\\ 1\\.015\ \(1\)\
\-\ source\\:\\ clean\\ catch\ \(1\)\
\-\ urine\\ culture\\:\\ no\\ growth\\ after\\ 2\\ days\ \(0\)\
\-\ urologist\\ consulted\\ believed\\ that\\ patient\\&\\#39\\;s\\ symptoms\\ were\\ likely\\ unrelated\\ to\\ the\\ calcifications\\ noted\\ on\\ imaging\\ especially\\ since\\ urinalysis\\ was\\ benign\\.\\ there\\ was\\ no\\ evidence\\ of\\ obstruction\\ and\\ the\\ pain\\ experienced\\ by\\ the\\ patient\\ was\\ not\\ lateralized\\.\\ \ \(0\)\
\-\ no\\ follow\\ up\\ for\\ this\\ condition\\ was\\ recommended\\ since\\ patient\\&\\#39\\;s\\ symptoms\\ resolved\\ with\\ bowel\\ clean\\ out\\.\ \(0\)\
\-\ imaging\\ done\\ prior\\ to\\ admission\\:\ \(0\)\
\-\ abdominal\\ x\\-ray\\ 1\\:\\ several\\ unchanged\\ calcifications\\ present\\ in\\ lower\\ pelvis\\,\\ below\\ the\\ level\\ of\\ the\\ ischial\\ spines\\,\\ may\\ be\\ representative\\ of\\ phleboliths\\.\\ ultrasound\\ recommended\\ to\\ exclude\\ ovarian\\ or\\ bladder\\ calcifications\\.\\ see\\ figure\\ 1\\.\\ \ \(0\)\
\-\ abdominal\\ ultrasound\\:\\ multiple\\ calcific\\ densities\\.\\ significant\\ shadowing\\ associated\\ with\\ the\\ areas\\ of\\ previous\\ deflux\\ procedure\\ but\\ ureteral\\ stones\\ trapped\\ at\\ the\\ orifice\\ cannot\\ be\\ excluded\\.\\ see\\ figure\\ 2\\.\\ \ \(0\)\
\-\ abdominal\\ ct\\ stone\\ protocol\\:\\ uterus\\ and\\ ovaries\\ appear\\ normal\\,\\ multiple\\ pelvic\\ calcifications\\.\\ largest\\ calcification\\ appears\\ to\\ be\\ at\\ ureteral\\ inlet\\ on\\ left\\ side\\ in\\ the\\ bladder\\,\\ widest\\ dimension\\ approximately\\ 8mm\\.\\ similar\\ smaller\\ lesions\\ present\\ on\\ the\\ right\\ side\\,\\ 5mm\\ in\\ maximum\\ dimension\\.\\ single\\ calcification\\ in\\ high\\ right\\ pelvis\\ could\\ be\\ in\\ ureter\\ or\\ could\\ be\\ a\\ fecalith\\.\\ concern\\ for\\ bilateral\\ stone\\ disease\\.\\ intravenous\\ pyelogram\\ \\(ivp\\)\\ recommended\\ for\\ evaluation\\ for\\ possible\\ obstruction\\.\\ see\\ figures\\ 3\\ and\\ 4\\.\\ \ \(0\)\
\-\ ivp\\:\\ kidneys\\ and\\ ureters\\ normal\\ in\\ position\\ and\\ size\\,\\ no\\ delay\\ in\\ excretion\\ of\\ contrast\\.\\ calcifications\\ present\\ in\\ distal\\ ureters\\ bilaterally\\ without\\ evidence\\ of\\ obstruction\\.\\ see\\ figure\\ 5\\.\ \(0\)\
\-\ imaging\\ done\\ while\\ admitted\\:\ \(0\)\
\-\ abdominal\\ x\\-ray\\ after\\ bowel\\ clean\\ out\\:\\ pelvic\\ calcifications\\ consistent\\ with\\ ureteral\\ stones\\ again\\ identified\\.\\ see\\ figure\\ 6\\.\ \(0\)\
\-\ sequela\\ of\\ deflux\\ procedure\ \(0\)\
\-\ phlebothiasis\ \(0\)\
\-\ ureteral\\ stone\\ disease\ \(0\)\
\-\ sequela\\ of\\ deflux\\ procedure\ \(0\)\
\-\ this\\ 8\\ y\\.o\\.\\ girl\\ has\\ a\\ history\\ of\\ irritable\\ bowel\\ syndrome\\ and\\ bilateral\\ vesicoureteral\\ reflux\\,\\ addressed\\ with\\ a\\ deflux\\ procedure\\ during\\ early\\ infancy\\.\\ she\\ presents\\ with\\ diffuse\\ acute\\ worsening\\ abdominal\\ pain\\,\\ nausea\\,\\ and\\ intermittent\\ non\\-bilious\\,\\ non\\-bloody\\ emesis\\ for\\ 3\\ weeks\\.\\ \ \(0\)\
\-\ for\\ the\\ past\\ year\\,\\ patient\\ has\\ been\\ taking\\ daily\\ fiber\\ and\\ miralax\\ prn\\.\\ the\\ patient\\ was\\ recently\\ started\\ on\\ levsin\\ 0\\.125mg\\ tablet\\ every\\ 4\\ hours\\,\\ as\\ needed\\ for\\ pain\\ but\\ reported\\ no\\ improvement\\ in\\ symptoms\\.\\ abdominal\\ imaging\\ was\\ done\\ some\\ days\\ before\\ admission\\.\ \(0\)\
\-\ approximately\\ 1\\%\\ of\\ children\\ worldwide\\ have\\ vesicoureteral\\ reflux\\ \\(vur\\)\\ which\\ is\\ graded\\ via\\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ from\\ grade\\ i\\ to\\ v\\ depending\\ on\\ how\\ retrograde\\ the\\ urine\\ is\\ able\\ to\\ travel\\ and\\ the\\ degree\\ of\\ ureteral\\ dilation\\.\\ \ \(0\)\
\-\ endoscopic\\ deflux\\ injection\\ has\\ been\\ associated\\ with\\ complications\\ including\\ hematuria\\,\\ both\\ gross\\ and\\ microscopic\\,\\ urinary\\ tract\\ infections\\,\\ rise\\ in\\ serum\\ creatinine\\ and\\ flank\\ pain\\.\\ rarely\\ complications\\ including\\ contralateral\\ vur\\ and\\ ureteral\\ obstruction\\ by\\ the\\ material\\ resulting\\ in\\ de\\ novo\\ hydronephrosis\\ have\\ been\\ observed\\ and\\ documented\\.\\ \ \(0\)\
\-\ there\\ are\\ now\\ also\\ reports\\,\\ including\\ this\\ one\\,\\ of\\ calcification\\ at\\ the\\ site\\ of\\ deflux\\ injection\\,\\ mimicking\\ stone\\ disease\\ on\\ imaging\\ but\\ without\\ associated\\ symptoms\\ or\\ signs\\ of\\ urinary\\ obstruction\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ deflux\\:\\ 0\\.08112440267453834\ \(0\)\
\-\ \\:\\:\\ 0\\.046805858944398704\ \(0\)\
\-\ ureteral\\:\\ 0\\.04609376626560901\ \(0\)\
\-\ figure\\:\\ 0\\.02927893960817146\ \(0\)\
\-\ calcifications\\:\\ 0\\.02923770326349159\ \(0\)\
\-\ clean\\:\\ 0\\.02810184765121605\ \(0\)\
\-\ negative\\:\\ 0\\.027400063082245584\ \(0\)\
\-\ stone\\:\\ 0\\.026080798972384432\ \(0\)\
\-\ obstruction\\:\\ 0\\.023108896078139842\ \(0\)\
\-\ procedure\\:\\ 0\\.02195752430145122\ \(0\)\
\-\ limits\\:\\ 0\\.02160867238798777\ \(0\)\
\-\ ivp\\:\\ 0\\.021545272867295837\ \(0\)\
\-\ vur\\:\\ 0\\.021072418021199954\ \(0\)\
\-\ abdominal\\:\\ 0\\.019655698510326215\ \(0\)\
\-\ see\\:\\ 0\\.0195568804542085\ \(0\)\
\-\ sequela\\:\\ 0\\.018734565100810698\ \(0\)\
\-\ admission\\:\\ 0\\.017326667561581112\ \(0\)\
\-\ bowel\\:\\ 0\\.01644143271708441\ \(0\)\
\-\ recommended\\:\\ 0\\.016299933429767263\ \(0\)\
\-\ done\\:\\ 0\\.016299933429767263\ \(0\)\
\-\ urinalysis\\:\\ 0\\.016135491909438908\ \(0\)\
\-\ ureters\\:\\ 0\\.016135491909438908\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.016049078176412233\ \(0\)\
\-\ imaging\\:\\ 0\\.01535332687465953\ \(0\)\
\-\ dimension\\:\\ 0\\.015041396989381449\ \(0\)\
\-\ normal\\:\\ 0\\.01438234230397808\ \(0\)\
\-\ calcification\\:\\ 0\\.014272019716827282\ \(0\)\
\-\ including\\:\\ 0\\.014196711538311\ \(0\)\
\-\ calprotectin\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ 0\\.2\\-1\\.0\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ 1\\.015\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ phlebothiasis\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ levsin\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ 0\\.125mg\\:\\ 0\\.013520733779089722\ \(0\)\
\-\ stones\\:\\ 0\\.013486741767392332\ \(0\)\
\-\ symptoms\\:\\ 0\\.013065383293853615\ \(0\)\
\-\ urine\\:\\ 0\\.012650829882629923\ \(0\)\
\-\ observed\\:\\ 0\\.01256754464009633\ \(0\)\
\-\ lateralized\\:\\ 0\\.012457624606451768\ \(0\)\
\-\ widest\\:\\ 0\\.012457624606451768\ \(0\)\
\-\ miralax\\:\\ 0\\.012457624606451768\ \(0\)\
\-\ injection\\:\\ 0\\.01223068922289631\ \(0\)\
\-\ 39\\:\\ 0\\.012181997967815666\ \(0\)\
\-\ urinary\\:\\ 0\\.01213406754480008\ \(0\)\
\-\ reflux\\:\\ 0\\.0121103802868433\ \(0\)\
\-\ non\\-bloody\\:\\ 0\\.011835745606285872\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.011818017772106107\ \(0\)\
\-\ pyelogram\\:\\ 0\\.011394515433813816\ \(0\)\
\-\ but\\:\\ 0\\.01118100184683152\ \(0\)\
\-\ ischial\\:\\ 0\\.011052270723209199\ \(0\)\
\-\ spines\\:\\ 0\\.011052270723209199\ \(0\)\
\-\ irritable\\:\\ 0\\.011052270723209199\ \(0\)\
\-\ novo\\:\\ 0\\.011052270723209199\ \(0\)\
\-\ catch\\:\\ 0\\.010772636433647918\ \(0\)\
\-\ fecalith\\:\\ 0\\.010772636433647918\ \(0\)\
\-\ fiber\\:\\ 0\\.010772636433647918\ \(0\)\
\-\ pelvic\\:\\ 0\\.01075843781154998\ \(0\)\
\-\ been\\:\\ 0\\.010696909000601187\ \(0\)\
\-\ bladder\\:\\ 0\\.010639297218555305\ \(0\)\
\-\ nitrites\\:\\ 0\\.010536209010599977\ \(0\)\
\-\ mimicking\\:\\ 0\\.010536209010599977\ \(0\)\
\-\ complications\\:\\ 0\\.010387033113533919\ \(0\)\
\-\ 7\\.0\\:\\ 0\\.010331406261175862\ \(0\)\
\-\ urobilinogen\\:\\ 0\\.010331406261175862\ \(0\)\
\-\ worldwide\\:\\ 0\\.010331406261175862\ \(0\)\
\-\ cystourethrogram\\:\\ 0\\.010331406261175862\ \(0\)\
\-\ \\#\\:\\ 0\\.010281247297364689\ \(0\)\
\-\ phleboliths\\:\\ 0\\.010150757433482023\ \(0\)\
\-\ be\\:\\ 0\\.010105496344662034\ \(0\)\
\-\ within\\:\\ 0\\.01000080618641768\ \(0\)\
\-\ addressed\\:\\ 0\\.009989161550571246\ \(0\)\
\-\ tablet\\:\\ 0\\.009989161550571246\ \(0\)\
\-\ prn\\:\\ 0\\.00984298029320265\ \(0\)\
\-\ suprapubic\\:\\ 0\\.009709527261009966\ \(0\)\
\-\ urologist\\:\\ 0\\.009709527261009966\ \(0\)\
\-\ could\\:\\ 0\\.009670423140584515\ \(0\)\
\-\ since\\:\\ 0\\.009628112336497597\ \(0\)\
\-\ infancy\\:\\ 0\\.009586762371940125\ \(0\)\
\-\ pelvis\\:\\ 0\\.009524820265618492\ \(0\)\
\-\ gravity\\:\\ 0\\.009473099837962023\ \(0\)\
\-\ trapped\\:\\ 0\\.009473099837962023\ \(0\)\
\-\ 8mm\\:\\ 0\\.009473099837962023\ \(0\)\
\-\ fecal\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ ketones\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ esterase\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ representative\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ orifice\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ non\\-bilious\\:\\ 0\\.009367282550405349\ \(0\)\
\-\ associated\\:\\ 0\\.009278201971967954\ \(0\)\
\-\ guaiac\\:\\ 0\\.00926829708853791\ \(0\)\
\-\ figures\\:\\ 0\\.00926829708853791\ \(0\)\
\-\ no\\:\\ 0\\.009237897323507077\ \(0\)\
\-\ signs\\:\\ 0\\.009225079552104462\ \(0\)\
\-\ \\&\\:\\ 0\\.009206711325587215\ \(0\)\
\-\ normoactive\\:\\ 0\\.009175314539739696\ \(0\)\
\-\ hazy\\:\\ 0\\.009175314539739696\ \(0\)\
\-\ voiding\\:\\ 0\\.009175314539739696\ \(0\)\
\-\ \\,\\:\\ 0\\.0091343887137735\ \(0\)\
\-\ was\\:\\ 0\\.009094578425279326\ \(0\)\
\-\ inlet\\:\\ 0\\.00908764826084407\ \(0\)\
\-\ side\\:\\ 0\\.009081124238540095\ \(0\)\
\-\ leukocyte\\:\\ 0\\.009004723074846715\ \(0\)\
\-\ travel\\:\\ 0\\.009004723074846715\ \(0\)\
\-\ present\\:\\ 0\\.008880408376986263\ \(0\)\
\-\ 0\\.2\\:\\ 0\\.008779871120564697\ \(0\)\
\-\ de\\:\\ 0\\.00871169357060943\ \(0\)\
\-\ out\\:\\ 0\\.00866274195355373\ \(0\)\
\-\ ph\\:\\ 0\\.008583807667328677\ \(0\)\
\-\ unrelated\\:\\ 0\\.008523653199302171\ \(0\)\
\-\ cmp\\:\\ 0\\.008465769260678173\ \(0\)\
\-\ yellow\\:\\ 0\\.008465769260678173\ \(0\)\
\-\ excretion\\:\\ 0\\.008465769260678173\ \(0\)\
\-\ vcug\\:\\ 0\\.008465769260678173\ \(0\)\
\-\ rise\\:\\ 0\\.008465769260678173\ \(0\)\
\-\ graded\\:\\ 0\\.008409990665324071\ \(0\)\
\-\ organomegaly\\:\\ 0\\.008356169622668748\ \(0\)\
\-\ microscopic\\:\\ 0\\.008356169622668748\ \(0\)\
\-\ pronounced\\:\\ 0\\.008304173377767397\ \(0\)\
\-\ unchanged\\:\\ 0\\.00825388223846833\ \(0\)\
\-\ 5mm\\:\\ 0\\.00825388223846833\ \(0\)\
\-\ ovaries\\:\\ 0\\.0081579921203988\ \(0\)\
\-\ approximately\\:\\ 0\\.008109870633606082\ \(0\)\
\-\ days\\:\\ 0\\.008033970233656373\ \(0\)\
\-\ crp\\:\\ 0\\.008024539088206117\ \(0\)\
\-\ consulted\\:\\ 0\\.007982516121659929\ \(0\)\
\-\ bilirubin\\:\\ 0\\.007901774199136275\ \(0\)\
\-\ believed\\:\\ 0\\.00786294320529534\ \(0\)\
\-\ retrograde\\:\\ 0\\.00786294320529534\ \(0\)\
\-\ documented\\:\\ 0\\.00786294320529534\ \(0\)\
\-\ for\\:\\ 0\\.007827848221624242\ \(0\)\
\-\ maximum\\:\\ 0\\.0077881116651581745\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0077764496472585995\ \(0\)\
\-\ in\\:\\ 0\\.007755777241845183\ \(0\)\
\-\ how\\:\\ 0\\.007752021945203889\ \(0\)\
\-\ calcific\\:\\ 0\\.007716761947926744\ \(0\)\
\-\ endoscopic\\:\\ 0\\.007716761947926744\ \(0\)\
\-\ or\\:\\ 0\\.007680389179169536\ \(0\)\
\-\ s\\:\\ 0\\.007517692230412844\ \(0\)\
\-\ creatinine\\:\\ 0\\.007460544026664218\ \(0\)\
\-\ largest\\:\\ 0\\.007431329003703032\ \(0\)\
\-\ emesis\\:\\ 0\\.007402660088040221\ \(0\)\
\-\ has\\:\\ 0\\.00738358882129269\ \(0\)\
\-\ densities\\:\\ 0\\.0072668419939582495\ \(0\)\
\-\ contralateral\\:\\ 0\\.007241064205129445\ \(0\)\
\-\ stool\\:\\ 0\\.007215712515020225\ \(0\)\
\-\ v\\:\\ 0\\.007190773065830379\ \(0\)\
\-\ at\\:\\ 0\\.007102841428414926\ \(0\)\
\-\ guarding\\:\\ 0\\.0070948829477608475\ \(0\)\
\-\ excluded\\:\\ 0\\.0070948829477608475\ \(0\)\
\-\ ureter\\:\\ 0\\.00707181871867413\ \(0\)\
\-\ reference\\:\\ 0\\.007049096194463791\ \(0\)\
\-\ protocol\\:\\ 0\\.007049096194463791\ \(0\)\
\-\ distention\\:\\ 0\\.007004636782081502\ \(0\)\
\-\ glucose\\:\\ 0\\.007004636782081502\ \(0\)\
\-\ culture\\:\\ 0\\.006982881206940465\ \(0\)\
\-\ systems\\:\\ 0\\.006961429915568165\ \(0\)\
\-\ exclude\\:\\ 0\\.006961429915568165\ \(0\)\
\-\ shadowing\\:\\ 0\\.006961429915568165\ \(0\)\
\-\ taking\\:\\ 0\\.006961429915568165\ \(0\)\
\-\ every\\:\\ 0\\.006961429915568165\ \(0\)\
\-\ source\\:\\ 0\\.006919406949021976\ \(0\)\
\-\ evidence\\:\\ 0\\.006872523261861588\ \(0\)\
\-\ rebound\\:\\ 0\\.006858455524712905\ \(0\)\
\-\ depending\\:\\ 0\\.006819126643404106\ \(0\)\
\-\ experienced\\:\\ 0\\.006799834032657387\ \(0\)\
\-\ daily\\:\\ 0\\.006780781087874324\ \(0\)\
\-\ protein\\:\\ 0\\.0067250024925202215\ \(0\)\
\-\ on\\:\\ 0\\.006661573733424186\ \(0\)\
\-\ esr\\:\\ 0\\.006636322169071103\ \(0\)\
\-\ diffusely\\:\\ 0\\.006619185204963548\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.006602237603450381\ \(0\)\
\-\ patient\\:\\ 0\\.006568956525432423\ \(0\)\
\-\ concern\\:\\ 0\\.006520199743096108\ \(0\)\
\-\ intravenous\\:\\ 0\\.006504305897949564\ \(0\)\
\-\ delay\\:\\ 0\\.006504305897949564\ \(0\)\
\-\ disease\\:\\ 0\\.006426706477986369\ \(0\)\
\-\ pain\\:\\ 0\\.006402504095280581\ \(0\)\
\-\ color\\:\\ 0\\.006397434854026267\ \(0\)\
\-\ appreciated\\:\\ 0\\.006382757781915606\ \(0\)\
\-\ 6\\.\\:\\ 0\\.006368219831065079\ \(0\)\
\-\ bilateral\\:\\ 0\\.006361404077651669\ \(0\)\
\-\ resolved\\:\\ 0\\.006353818388810724\ \(0\)\
\-\ smaller\\:\\ 0\\.006353818388810724\ \(0\)\
\-\ serum\\:\\ 0\\.006325414941314961\ \(0\)\
\-\ again\\:\\ 0\\.00629752794885608\ \(0\)\
\-\ rarely\\:\\ 0\\.006283772320048165\ \(0\)\
\-\ vital\\:\\ 0\\.006270138965113739\ \(0\)\
\-\ gross\\:\\ 0\\.006243230514728909\ \(0\)\
\-\ 1\\:\\ 0\\.006237197447729163\ \(0\)\
\-\ infections\\:\\ 0\\.006229951277392843\ \(0\)\
\-\ hematuria\\:\\ 0\\.006216786026332427\ \(0\)\
\-\ \\;\\:\\ 0\\.006212948430836177\ \(0\)\
\-\ uterus\\:\\ 0\\.006177955032491492\ \(0\)\
\-\ able\\:\\ 0\\.006177955032491492\ \(0\)\
\-\ dilation\\:\\ 0\\.006177955032491492\ \(0\)\
\-\ without\\:\\ 0\\.006171819528706013\ \(0\)\
\-\ flank\\:\\ 0\\.006165226807315578\ \(0\)\
\-\ degree\\:\\ 0\\.006140082927291534\ \(0\)\
\-\ 3\\:\\ 0\\.0061379617383636184\ \(0\)\
\-\ recently\\:\\ 0\\.006115344611448155\ \(0\)\
\-\ improvement\\:\\ 0\\.006115344611448155\ \(0\)\
\-\ kidneys\\:\\ 0\\.0060317737751228945\ \(0\)\
\-\ ovarian\\:\\ 0\\.005997306204797652\ \(0\)\
\-\ cbc\\:\\ 0\\.005856297776384024\ \(0\)\
\-\ material\\:\\ 0\\.005856297776384024\ \(0\)\
\-\ started\\:\\ 0\\.005845969506167238\ \(0\)\
\-\ tract\\:\\ 0\\.005805338194131998\ \(0\)\
\-\ resulting\\:\\ 0\\.005756017470766153\ \(0\)\
\-\ needed\\:\\ 0\\.0057082334711038895\ \(0\)\
\-\ growth\\:\\ 0\\.005698852754819478\ \(0\)\
\-\ below\\:\\ 0\\.005689529064518278\ \(0\)\
\-\ have\\:\\ 0\\.005676190424432797\ \(0\)\
\-\ admitted\\:\\ 0\\.0056618933198822686\ \(0\)\
\-\ children\\:\\ 0\\.0056618933198822686\ \(0\)\
\-\ 5\\.\\:\\ 0\\.005652790964790529\ \(0\)\
\-\ intermittent\\:\\ 0\\.0056258035999279836\ \(0\)\
\-\ via\\:\\ 0\\.0056258035999279836\ \(0\)\
\-\ before\\:\\ 0\\.005547578823160541\ \(0\)\
\-\ site\\:\\ 0\\.005539128430812427\ \(0\)\
\-\ multiple\\:\\ 0\\.005520877311286101\ \(0\)\
\-\ condition\\:\\ 0\\.0054812444921884295\ \(0\)\
\-\ position\\:\\ 0\\.005457090570458155\ \(0\)\
\-\ after\\:\\ 0\\.005423316572420867\ \(0\)\
\-\ specific\\:\\ 0\\.00541766057550385\ \(0\)\
\-\ i\\:\\ 0\\.00541766057550385\ \(0\)\
\-\ especially\\:\\ 0\\.005394480149414818\ \(0\)\
\-\ appear\\:\\ 0\\.0053641080216599414\ \(0\)\
\-\ single\\:\\ 0\\.005312362408727656\ \(0\)\
\-\ results\\:\\ 0\\.005290709216172771\ \(0\)\
\-\ reports\\:\\ 0\\.005283558889323367\ \(0\)\
\-\ range\\:\\ 0\\.005276441742764314\ \(0\)\
\-\ nausea\\:\\ 0\\.005276441742764314\ \(0\)\
\-\ sounds\\:\\ 0\\.005227525540653957\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0051602453533754564\ \(0\)\
\-\ worsening\\:\\ 0\\.0051602453533754564\ \(0\)\
\-\ moderate\\:\\ 0\\.005153676853694474\ \(0\)\
\-\ hours\\:\\ 0\\.005153676853694474\ \(0\)\
\-\ similar\\:\\ 0\\.005140623648682344\ \(0\)\
\-\ previous\\:\\ 0\\.005089494169744319\ \(0\)\
\-\ grade\\:\\ 0\\.004992080970783697\ \(0\)\
\-\ 8\\:\\ 0\\.004900487052529675\ \(0\)\
\-\ appears\\:\\ 0\\.004878418436805596\ \(0\)\
\-\ laboratory\\:\\ 0\\.004829895300389672\ \(0\)\
\-\ early\\:\\ 0\\.00479318860374607\ \(0\)\
\-\ reported\\:\\ 0\\.004777722163459834\ \(0\)\
\-\ identified\\:\\ 0\\.004683231658261229\ \(0\)\
\-\ girl\\:\\ 0\\.004607940845076377\ \(0\)\
\-\ to\\:\\ 0\\.004585087053835742\ \(0\)\
\-\ benign\\:\\ 0\\.004523083385020247\ \(0\)\
\-\ now\\:\\ 0\\.004480238634511729\ \(0\)\
\-\ \\(\\:\\ 0\\.004431667032170923\ \(0\)\
\-\ this\\:\\ 0\\.0044224104907092015\ \(0\)\
\-\ possible\\:\\ 0\\.004414083157797657\ \(0\)\
\-\ areas\\:\\ 0\\.004410041673690287\ \(0\)\
\-\ size\\:\\ 0\\.004393981397820202\ \(0\)\
\-\ \\)\\:\\ 0\\.004377531853455859\ \(0\)\
\-\ palpation\\:\\ 0\\.0043741396937853555\ \(0\)\
\-\ by\\:\\ 0\\.004364634672530291\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004304762635772858\ \(0\)\
\-\ several\\:\\ 0\\.004213332570126361\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0041678591131905805\ \(0\)\
\-\ follow\\:\\ 0\\.004164416368016003\ \(0\)\
\-\ past\\:\\ 0\\.004164416368016003\ \(0\)\
\-\ area\\:\\ 0\\.0041439206198378336\ \(0\)\
\-\ and\\:\\ 0\\.004141311481569443\ \(0\)\
\-\ while\\:\\ 0\\.00412369515314772\ \(0\)\
\-\ 1\\.\\:\\ 0\\.004093848414566873\ \(0\)\
\-\ during\\:\\ 0\\.004010750383318724\ \(0\)\
\-\ tenderness\\:\\ 0\\.003986061844910481\ \(0\)\
\-\ some\\:\\ 0\\.003979951309611594\ \(0\)\
\-\ diffuse\\:\\ 0\\.00396780279198668\ \(0\)\
\-\ there\\:\\ 0\\.00390096796461653\ \(0\)\
\-\ abdomen\\:\\ 0\\.0038824912007602705\ \(0\)\
\-\ evaluation\\:\\ 0\\.0038071147175257787\ \(0\)\
\-\ not\\:\\ 0\\.0037877873366317038\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0037827905407771473\ \(0\)\
\-\ level\\:\\ 0\\.0037774371589676873\ \(0\)\
\-\ appearance\\:\\ 0\\.0037483229704519043\ \(0\)\
\-\ syndrome\\:\\ 0\\.0037483229704519043\ \(0\)\
\-\ weeks\\:\\ 0\\.003719751160891332\ \(0\)\
\-\ time\\:\\ 0\\.0037018423730664305\ \(0\)\
\-\ likely\\:\\ 0\\.003696763751435056\ \(0\)\
\-\ she\\:\\ 0\\.0036791198488560924\ \(0\)\
\-\ 4\\:\\ 0\\.0036517974005813576\ \(0\)\
\-\ the\\:\\ 0\\.003604659263744844\ \(0\)\
\-\ high\\:\\ 0\\.0035867270875411285\ \(0\)\
\-\ blood\\:\\ 0\\.003577317595873159\ \(0\)\
\-\ distal\\:\\ 0\\.0035633107192423723\ \(0\)\
\-\ one\\:\\ 0\\.003551735250476448\ \(0\)\
\-\ up\\:\\ 0\\.003524305446402183\ \(0\)\
\-\ significant\\:\\ 0\\.003524305446402183\ \(0\)\
\-\ lesions\\:\\ 0\\.00350852838396311\ \(0\)\
\-\ mild\\:\\ 0\\.0034513089784219894\ \(0\)\
\-\ prior\\:\\ 0\\.0033652036383471835\ \(0\)\
\-\ both\\:\\ 0\\.0033469325010523332\ \(0\)\
\-\ more\\:\\ 0\\.00327787777501866\ \(0\)\
\-\ acute\\:\\ 0\\.0032360112409608823\ \(0\)\
\-\ physical\\:\\ 0\\.003215498879725826\ \(0\)\
\-\ consistent\\:\\ 0\\.0032136476515816\ \(0\)\
\-\ soft\\:\\ 0\\.003191605466247776\ \(0\)\
\-\ noted\\:\\ 0\\.0031064742154180884\ \(0\)\
\-\ \\%\\:\\ 0\\.003057240848690196\ \(0\)\
\-\ other\\:\\ 0\\.003020918019482283\ \(0\)\
\-\ were\\:\\ 0\\.0029758992894017198\ \(0\)\
\-\ can\\:\\ 0\\.0029727336694310882\ \(0\)\
\-\ lower\\:\\ 0\\.002947641210680771\ \(0\)\
\-\ contrast\\:\\ 0\\.0029337050411164193\ \(0\)\
\-\ exam\\:\\ 0\\.002879193159431807\ \(0\)\
\-\ may\\:\\ 0\\.002874736762113687\ \(0\)\
\-\ 2\\:\\ 0\\.0028222461602922487\ \(0\)\
\-\ right\\:\\ 0\\.0027657414389890083\ \(0\)\
\-\ of\\:\\ 0\\.0026803021655978933\ \(0\)\
\-\ presents\\:\\ 0\\.0026773685513925244\ \(0\)\
\-\ also\\:\\ 0\\.00258377238292968\ \(0\)\
\-\ which\\:\\ 0\\.0024465407779793694\ \(0\)\
\-\ that\\:\\ 0\\.0022637741235564776\ \(0\)\
\-\ as\\:\\ 0\\.001982480837260932\ \(0\)\
\-\ from\\:\\ 0\\.0019423860631199576\ \(0\)\
\-\ ct\\:\\ 0\\.0018332878119509861\ \(0\)\
\-\ a\\:\\ 0\\.0018248457138892698\ \(0\)\
\-\ history\\:\\ 0\\.0018101449964832569\ \(0\)\
\-\ are\\:\\ 0\\.0017866163689104321\ \(0\)\
\-\ is\\:\\ 0\\.001724818338603453\ \(0\)\
\-\ \\.\\:\\ 0\\.0015789670963543589\ \(0\)\
\-\ left\\:\\ 0\\.0014664191246517098\ \(0\)\
\-\ year\\:\\ 0\\.0014664191246517098\ \(0\)\
\-\ with\\:\\ 0\\.0010767255468394762\ \(0\)\
